Latest News

Rs 500 fees for first 20 students
No Experience Required

• You don’t need to be part of a company to become certified
• You don’t need to have any on-the-job experience
• You don’t even need to spend a penny to take the official exam

Who this course is for :

• Any graduate (BCOM, BSC, and BCA. Etc or 10+2 and job Seeker
• BUSY PEOPLE who want to become certified in the shortest time possible
• MARKETERS who want to increase their earning potential and career prospects
• FREELANCERS looking to attract more leads and more sales
• WEBSITE OWNERS who want learn Google Analytics as quickly and effectively as possible

Serum Institute of India from Pune and Dr.Reddy’s Bharat BioTech,Hyderabad have emerged strong players. There have been rampant developments regarding the making of homegrown vaccines too. Bharat BioTech's Covaxin, Zydus Cadila's ZyCoV-D, are soon heading into critical phase III. 5 other vaccines are under pre-clinical and early stages of development. Trials for Ayurvedic drugs and preventive medicines are being carried out as well.

India occupies a prime, strategic position in global vaccine hunt. With a large manpower and production facilities, the nation will witness production and testing happen at a large scale. Strategic partnerships will allow India to even get priority access to any vaccine which is developed first hand. USA,UK, RUSSIA & CHINA are in the top 5 list .

Nirmala Sitharaman said Rs 64,180 crore will be allocated for the Atmanirbhar Swasth Bharat Yojana new national health programme, over the next six years, to advance primary, secondary and tertiary healthcare.

The program funds will be dedicated to developing primary, secondary and tertiary healthcare in the country. This will be in addition to the National Health Mission and help support both urban and rural health centres. It is also looking at establishing of 12 central institutions while strengthening the National Center for Disease Control, expansion of the health information portal to all states and Union Territories to connect all health labs.

She also said that the Government of India will be merging the supplementary nutrition programme and Poshan Abhiyan to launch Mission Poshan 2.0 which aims to strengthen the nutritional content, delivery and outreach.

Finance Minister announced Rs 2,83,846 lakh crores for the health and wellness sector which will also include Rs 35,000 crores for COVID-19 vaccines and also said that she is committed to spending more if needed. This money will be used for the development and distribution of the vaccines. She said this amounts to a 137 percent increase in the health allocations from the previous Financial Year.

SGenomic medicine helps in determining risk scores for various possible health conditions. In the rapidly evolving field of healthcare protocols and advancements in treatments of various diseases and health conditions, two city doctors have been digging deep, down to the genetic information level, in a bid to ensure best possible outcomes for their patients.
This is the next step in medical care,” says Dr Kalyan Uppuluri, from K&H Personalized Medicine Clinic. He, along with Dr Hima Challa, are the founders of the clinic, the first of its kind in the country to offer services bringing genomic medicine into clinical Medicare. Armed with degrees in medical genomics from Stanford University and Harvard Medical School respectively.
The challenge for them was to translate molecular biology level data into medical language. A team of molecular biologists armed with advanced degrees dug deep into published research and after studying thousands of research papers, gathered data on around 8,000 genes and switched what each of them do and what that means in medical language.
Genomic medicine helps in determining risk scores for various possible health conditions and these scores remain more or less stable through one’s life. Clinical risk scores can change, and can be changed for the better based on follow up advice from physicians, especially when coupled with knowledge of the genetic risk scores, she says.
“Our view is that personalized medicine is the future. Patients will be in a position, when their doctors have the assistance of genomic medicine, to be assured that they are in a position to achieve the best possible outcomes for their treatment,” says Dr Kalyan Uppuluri.
Medicines of the future will evolve based on genomics, he predicts. “We see this already in oncology, for treating cancers. Genomics is already helping in attacking this disease’s pathways,” he says.